Skip to content

Similar papers

Review Open access Nov 2026

Senescent cells in cancer immunity: mechanisms of immune remodeling and opportunities for traditional Chinese medicine-derived senotherapeutics

Cellular senescence has context-dependent effects in cancer. Although transient senescence can suppress malignant proliferation, persistent senescent cells in the tumor microenvironment (TME) may promote tumor progression, immune escape and treatment resistance. How these cells reshape antitumor immunity, and whether t...

Qiu-Hua Zhang, Hui-Min Jin, Ling-Yong Cao et al. · 0 citations
Open access Oct 2026

Cellular senescence in ovarian cancer: context-dependent effects on tumor immunity and therapy response

Cellular senescence is a stress-responsive state marked by sustained proliferative arrest and changes in metabolism, chromatin organization, secretion, and immune signaling. In ovarian cancer (OC), platinum therapy and PARP inhibition can generate senescence-associated states with distinct consequences. Their effects d...

Yu-Bo Zhang, Meng-Qi Deng, Jun-Yi Jiang · 0 citations
Review Open access Oct 2026

Targeting senescence-mediated immune resistance for enhanced tumor immunotherapy

Cellular senescence, a stable state of cell cycle arrest triggered by intrinsic and extrinsic stressors, has emerged as a pivotal regulator of tumor immunity and therapeutic resistance. Senescent cells exhibit pronounced temporal heterogeneity in immune modulation. Early-stage senescence enhances antitumor immunity by...

Si-Yu Chen, Jing Su, Ao-Jia Jin et al. · 0 citations
Open access Sep 2026

Senescence-associated transcriptional reprogramming in the tumor immune microenvironment: Mechanistic layers and therapeutic opportunities

The tumor immune microenvironment (TIME) is a principal determinant of tumor progression, metastatic dissemination, and therapeutic response. Cellular senescence, primarily through the senescence-associated secretory phenotype (SASP), progressively reshapes the TIME toward immunosuppressive and therapy-resistant states...

Xiao Yu, Jian-Lei Xing, Xu-Dong Zhao et al. · 0 citations
Review Open access Oct 2026

Tumor-associated macrophage reprogramming in cancer: recent advances in resistance mechanisms and therapy

Tumor-associated macrophages (TAMs) are abundant, heterogeneous, and spatially organized immune cells that regulate cancer progression, immune evasion, metastasis, and therapeutic resistance. Single-cell and spatial technologies have revealed diverse TAM states shaped by ontogeny, tumor type, disease stage, cytokines,...

Abdullah Farhan Saeed, M. Ashraf, Muhammad Iqbal · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.